Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-15T14:47:16.111Z Has data issue: false hasContentIssue false

Cost-effectiveness of a primary care model for anxiety disorders

Published online by Cambridge University Press:  02 January 2018

Hans-Helmut König*
Affiliation:
MPH, Health Economics Research Unit, Department of Psychiatry
Anja Born
Affiliation:
Health Economics Research Unit, Department of Psychiatry, and Department of Medical Psychology and Medical Sociology
Dirk Heider
Affiliation:
Health Economics Research Unit, Department of Psychiatry
Herbert Matschinger
Affiliation:
Department of Psychiatry
Sven Heinrich
Affiliation:
Health Economics Research Unit, Department of Psychiatry
Steffi G. Riedel-Heller
Affiliation:
Public Health Research Unit, Department of Psychiatry
Daniel Surall
Affiliation:
Department of Psychiatry, University of Leipzig, Germany
Matthias C. Angermeyer
Affiliation:
Center for Public Mental Health, Gösing am Wagram, Austria
Christiane Roick
Affiliation:
Health Economics Research Unit, Department of Psychiatry, University of Leipzig, Germany
*
Hans-Helmut König, MPH, University of Leipzig, Health Economics Research Unit, Department of Psychiatry, Liebigstr. 26, D-04103 Leipzig, Germany. Email: hans-helmut.koenig@medizin.uni-leipzig.de
Rights & Permissions [Opens in a new window]

Abstract

Background

Individuals with anxiety disorders often do not receive an accurate diagnosis or adequate treatment in primary care.

Aims

To analyse the cost-effectiveness of an optimised care model for people with anxiety disorders in primary care.

Method

In a cluster randomised controlled trial, 46 primary care practices with 389 individuals positively screened with anxiety were randomised to intervention (23 practices, 201 participants) or usual care (23 practices, 188 participants). Physicians in the intervention group received training on diagnosis and treatment of anxiety disorders combined with the offer of a psychiatric consultation–liaison service for 6 months. Anxiety, depression, quality of life, service utilisation and costs were assessed at baseline, 6-month and 9-month follow-up.

Results
Results

No significant differences were observed between intervention and control group on the Beck Anxiety Inventory, Beck Depression Inventory and EQ–5D during follow-up. Total costs were higher in the intervention group (€4911 v. €3453, P = 0.09). The probability of an incremental cost-effectiveness ratio <€50 000 per quality-adjusted life year was below 10%.

Conclusions

The optimised care model did not prove to be cost-effective.

Information

Type
Papers
Copyright
Copyright © Royal College of Psychiatrists, 2009 
Figure 0

Fig. 1CONSORT diagram showing the flow of clusters and participants through the trial.

Figure 1

Table 1Scores of outcome measures in intervention and control group at T0, T1 and T2

Figure 2

Table 2Mean costs, mean quality-adjusted life-years (QALYs) and incremental cost-effectiveness ratios (ICERs) during follow-up

Figure 3

Fig. 2Joint distribution of incremental (a) direct costs and (b) total costs and incremental quality-adjusted life-years (QALYs) of the optimised care model plotted in the cost-effectiveness plane. Results of non-parametric bootstrapping with 4000 replications taking into account clusters and strata.

Figure 4

Fig. 3Cost-effectiveness acceptability curves of the optimised care model taking into account direct costs only or total costs. ICER, incremental cost-effectiveness ratio.

Figure 5

AppendixResources, units and monetary valuation used for calculation of costs

Supplementary material: PDF

König et al. supplementary material

Supplementary Table S1-S2

Download König et al. supplementary material(PDF)
PDF 46.5 KB

This journal is not currently accepting new eletters.

eLetters

No eLetters have been published for this article.